Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025

Modified poxviruses, including modified smallpox virus vaccine based on recombinant drug-sensitive vaccinia virus, and new selection methods

US Patent 7025970 · Granted Apr 11, 2006

Estimated economic value: $17,652,000

Assignee

Inventors

View full patent text on Google Patents →